Zobrazeno 1 - 5
of 5
pro vyhledávání: '"Beer JP"'
Autor:
Beer JP, Ian
Publikováno v:
Education + Training, 1985, Vol. 27, Issue 5, pp. 158-160.
Externí odkaz:
http://www.emeraldinsight.com/doi/10.1108/eb017146
Akademický článek
Tento výsledek nelze pro nepřihlášené uživatele zobrazit.
K zobrazení výsledku je třeba se přihlásit.
K zobrazení výsledku je třeba se přihlásit.
Autor:
Ian Beer Jp
Publikováno v:
Education + Training. 27:158-160
We have a problem with our sixth forms; it is a comparatively new one since, until recently, sixth form education in England has been respected across the world for its ability to motivate a pupil's mind to delve in depth into a limited number of sub
Autor:
Clarke CA; GRAIL, Menlo Park, California, USA., Mitchell BL; Natera, Austin, Texas, USA., Putcha G; Precision Medicine & Diagnostics, Los Altos Hills, California, USA., Alme E; Guardant Health, Redwood City, California, USA., Bach P; Delfi, Baltimore, Maryland, USA., Beer JP; Bristol Myers Squibb, Princeton, New Jersey, USA., Beer TM; Exact Sciences, Madison, Wisconsin, USA., Beidelschies MA; Exact Sciences, Madison, Wisconsin, USA., Hoyos J; Prevent Cancer Foundation, Alexandria, Virginia, USA., Klein E; GRAIL, Menlo Park, California, USA., Kuhn P; University of Southern California, Los Angeles, California, USA., Krunic N; Novartis, East Hanover, New Jersey, USA., Lang K; Freenome, San Francisco, California, USA., Lee JSH; University of Southern California, Los Angeles, California, USA., Lopez Ramos D; BLOODPAC, Chicago, Illinois, USA., Morgenstern D; Delfi, Baltimore, Maryland, USA., Quinn E; AstraZeneca, Wilmington, Delaware, USA., Raymond VM; Guardant Health, Redwood City, California, USA., Rubinstein WS; National Institutes of Health/National Cancer Institute, Rockville, Maryland, USA., Sanchez SA; Natera, Austin, Texas, USA., Serra R; Quest Diagnostics, Secaucus, New Jersey, USA., Stewart M; Friends of Cancer Research, Washington, District of Columbia, USA., Leiman LC; BLOODPAC, Chicago, Illinois, USA.
Publikováno v:
Clinical and translational science [Clin Transl Sci] 2024 Sep; Vol. 17 (9), pp. e70016.
Autor:
Clarke CA; GRAIL LLC, Menlo Park, California, USA., Lang K; Guardant Health, Redwood City, California, USA., Putcha G; Freenome, South San Francisco, California, USA., Beer JP; Novartis, Cambridge, Massachusetts, USA., Champagne M; Illumina, San Diego, California, USA., Ferris A; Lungevity Foundation, Bethesda, Maryland, USA., Godsey JH; Quest Diagnostics, Irvine, California, USA., Grossman RL; Open Commons Consortium, Chicago, Illinois, USA., Hoyos JM; Prevent Cancer Foundation, Alexandria, Virginia, USA., Johann DJ; University of Arkansas for Medical Sciences, Little Rock, Arkansas, USA., Krunic N; Novartis, Cambridge, Massachusetts, USA., Kuhn P; University of Southern California, Los Angeles, California, USA., Lee JSH; University of Southern California, Los Angeles, California, USA., Maddala T; Delfi Diagnostics, Palo Alto, California, USA., Mata M; Pfizer, San Diego, California, USA., McDole J; Bio-Rad Laboratories Inc, Digital Biology Group, Pleasanton, California, USA., Perez O; AstraZeneca, Gaithersburg, Maryland, USA., Scher H; Memorial Sloan Kettering Cancer Center, New York, New York, USA., Stewart MD; Friends of Cancer Research, Washington, DC, USA., Bhan SS; EXACT Sciences, Madison, Wisconsin, USA., Zhang Q; GlaxoSmithKline, Collegeville, Pennsylvania, USA., Leiman LC; BLOODPAC, Chicago, Illinois, USA.
Publikováno v:
Clinical and translational science [Clin Transl Sci] 2023 Jan; Vol. 16 (1), pp. 5-9. Date of Electronic Publication: 2022 Oct 17.